At the news
? NEUTRALIMPACT 2/10 3 filed Jun 15, 2026 at 18:48 ET
Brian N. Cherry filed a Form 3 initial statement of beneficial ownership, reporting 38,320 shares of Atara Biotherapeutics common stock. This is a routine insider filing required upon becoming a Section 16 reporting person and conveys no material new information about the company's operations or financial condition.
- Brian N. Cherry filed Form 3 as a new Section 16 reporting person of Atara Biotherapeutics, Inc.
- Cherry reported beneficial ownership of 38,320 shares of common stock.
- The filing includes a power of attorney authorizing Yanina Grant-Huerta and John Chao to execute Section 16 filings on his behalf.
- The filing date is June 15, 2026, with a period of report of June 11, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access